New drug trial aims to stop Alzheimer's before it starts in High-Risk group
NCT ID NCT07399171
Summary
This study is testing an investigational drug called HT-4253 to see if it can prevent Alzheimer's disease in people who carry the APOE4 gene and have early biological signs of the disease but no memory symptoms. It will enroll 112 healthy adults aged 50-75. Participants will receive either the drug or a placebo for 48 weeks to see if the treatment can lower their biological risk score for developing Alzheimer's.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMERS DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic Abu Dhabi
Abu Dhabi, United Arab Emirates
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.